Skip to content
  • Contacts
  • facebook
  • twitter
  • linkedin
registration | login

News and Events

The official online journal of the International Conference
on Thrombosis and Hemostasis Issues in Cancer
Recording available for the “Long-term treatment & DDI implications in the management of CAT” by ICTHIC Editorial Office 31 October 2022
Recording available for the webinar “Updates in Cancer-Associated Thrombosis” by ICTHIC Editorial Office 20 September 2022
Recording available for the webinar: What is the profile of the Real-World CAT patient? by ICTHIC Editorial Office 25 July 2022
Did you miss the 11th ICTHIC? Discover the highlights here by ICTHIC Editorial Office 15 July 2022
  • Home
  • Thrombosis and cancer
    • Epidemiology
    • Basic Mechanisms
    • Prevention
    • Trials and Therapy
    • Focus on: Atrial fibrillation
    • Focus on: Pediatrics
    • Focus on: COVID-19
  • Guidelines and Tools
  • Congress reports
    • ICTHIC 2022
    • ICTHIC 2021
    • ISTH 2020
    • ASH 2020
    • ASH 2019
    • ISTH 2019
    • ICTHIC 2018
    • ESC 2018
  • News and Events
  • Past webinars
  • About
  • Contacts
  • Editorial Board
  • Most Read
  • Podcast and videos
  • Archive
  • PARTNERSHIP
Webinar

Home › Thrombosis and cancer › Page 12

Thrombosis and cancer

Bleeding complications and platelet dysfunction in patients with lymphoproliferative disease receiving Bruton tyrosine kinase inhibitors

Ibrutinib (IBR) is an irreversible inhibitor of Bruton tyrosine kinase (Btk) that is approved for the treatment of...
Author Erica De CandiaPosted on 5 March 201827 December 2019

Managing antithrombotic medication in thrombocytopenia

Cancer is associated with an increased risk of venous but also arterial thrombosis1. Moreover, contemporary anticancer...
Author Avi LeaderPosted on 2 March 201829 December 2019

Anticoagulants for cancer survival

Max is a 61-year-old male who works as a consultant cardiologist at your same institution and who has recently been...
Author Ramon LecumberriPosted on 27 February 201827 December 2019

New perspectives for the treatment of cancer-associated thrombosis

New perspectives for the treatment of cancer-associated thrombosis Patients with cancer-associated thrombosis (CAT)...
Author Paolo PrandoniPosted on 7 February 201827 December 2019

Trial updates In thromboprophylaxis of cancer-related venous thromboembolism

The past decade has seen a large number of studies focusing on identifying cancer patients at high risk for venous...
Author Alok KhoranaPosted on 7 February 201827 December 2019

Rational for new promising studies on occult cancer screening for patients with unprovoked venous thromboembolism

Venous thromboembolism (VTE), comprising deep vein thrombosis and pulmonary embolism, can be the first sign of an...
Author Marc CarrierPosted on 7 February 201827 December 2019

The role of polymorphisms in coagulation factor genes in cancer susceptibility

Mari Tinholt1,2, Nina Iversen1 and Per Morten Sandset2,3,* 1Department of Medical Genetics, Oslo University Hospital,...
Author Per Morten SandsetPosted on 11 December 20178 January 2020

The role of microparticles in VTE

Cancer-associated venous thromboembolism (VTE) causes significant morbidity and mortality in patients and constitutes...
Author Christophe DuboisPosted on 11 December 201727 December 2019

New studies in prevention and treatment of cancer-associated thrombosis

The landmark CLOT Study changed practice by demonstrating that dalteparin monotherapy was more effective than LMWH...
Author Charles FrancisPosted on 11 December 201727 December 2019

Management of bleeding complications in cancer patients on DOACs

Major bleeding can be life or limb threatening and incurs substantial health care costs, whereas clinically relevant...
Author Sam SchulmanPosted on 27 October 201727 December 2019

Posts navigation

Previous page Page 1 … Page 11 Page 12 Page 13 Next page

ICTHIC magazine is supported by the unrestricted educational grant from

SUBSCRIBE TO OUR NEWSLETTER

I agree to receive updates concerning the content published in ICTHIC MAGAZINE and related promotional content/activities (more details)

logo polistudium
Scientific and Web contents by Polistudium s.r.l.
Via Anfossi 36, 20135 Milan, Italy
info@polistudium.it
None of the information published on the ICTHC magazine website, in particular, information related to the choice and use of drugs, replaces the advice of a doctor
© COPYRIGHT 2019 ICTHIC Magazine
Privacy policy
None of the information published on the ICTHC magazine website, in particular, information related to the choice and use of drugs, replaces the advice of a doctor.

Accept to continue
By registering to the newsletter, the User’s email address will be added to the contact list of ICTHIC Magazine, in order to receive email messages concerning the content published in ICTHIC Magazine and related promotional content/activities. Your email address may also be added to this list as a result of signing up to this Website. Personal Data collected: email address, first name, last name, profession.
ICTHIC CONFERENCE Newsletter By registering to the newsletter, the User’s email address will be added to the contact list of ICTHIC, in order to receive newsletters concerning the conference, such as Save the date, information about the meeting venue, the publication of the program, registration fees and deadline, abstract submission deadline and oral communication/poster instructions, hotel booking availability and deadline, social program for accompanying persons, the publication of speakers slides, photo/videogallery of the last edition and information about future editions of the conference. Your email address may also be added to this list as a result of signing up to this Website.